TRADE NEWS: Agilent Technologies Inc.'s Bioinformatics Suite To Enable Standardization Of Platforms At Federal Agency

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE:A) announced today that the National Cancer Institute (NCI) has purchased a full site license for a wide range of Agilent bioinformatics solutions.
MORE ON THIS TOPIC